BACTERIAL INFECTION-ASSOCIATED IMPROVEMENT OF PLATELET COUNTS IN 2 PATIENTS WITH CHRONIC AND UNRESPONSIVE IDIOPATHIC THROMBOCYTOPENIC PURPURA WITH NORMAL PLATELET SURVIVAL STUDIES

被引:3
作者
BORDIN, JO
SMITH, JW
HAYWARD, CPM
WARKENTIN, TE
WASI, P
KELTON, JG
机构
[1] MCMASTER UNIV,MED CTR,DEPT MED & PATHOL,HAMILTON,ON L8N 3Z5,CANADA
[2] CANADIAN RED CROSS BLOOD TRANSFUS SERV,HAMILTON CTR,HAMILTON,ON,CANADA
关键词
REFRACTORY ITP; BACTERIAL INFECTION; PLATELET COUNT;
D O I
10.1111/j.1365-2141.1995.tb05154.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Approximately 20% of adult patients with idiopathic thrombocytopenic purpura (ITP) do not respond to splenectomy and require alternative therapies to achieve a clinically safe platelet count. A small percentage of these patients have very refractory disease and are either unresponsive or poorly responsive to almost any therapy. In this report we describe two patients with chronic and unresponsive ITP with normal platelet survivals. Neither patient had responded to a large variety of treatments including corticosteroids, splenectomy, IVIgG, anti-D, chemotherapy, and ascorbic acid. However, both had a rapid, but short-lived, rise in their platelet count following a bacterial infection, One patient had a rise in platelet count for 6 months following the acute episode of bacteraemia, The second patient had a shorter response of 1 week. It is possible that these two patients represent a subset of patients with ITP who may benefit from cytokine therapy.
引用
收藏
页码:332 / 335
页数:4
相关论文
共 16 条
  • [1] Aggarwal B.B., Pocsik E., Cytokines: from clone to clinic, Archives of Biochemistry and Biophysics, 292, pp. 335-359, (1992)
  • [2] Ballem P.J., Segal G.M., Stratton J.R., Gernsheimer T., Adamson J.W., Slichter, Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura, Journal of Clinical Investigation, 80, pp. 33-40, (1987)
  • [3] Berchtold P., McMillan R., Therapy of chronic idiopathic thrombocytopenic purpura in adults, Blood, 74, pp. 2309-2317, (1989)
  • [4] Boshkov L.K., Kelton J.G., Halloran P.F., HLA‐DR expression by platelets in acute idiopathic thrombocytopenic purpura, British Journal of Haematology, 81, pp. 552-557, (1992)
  • [5] Briddell R.A., Hoffman R., Cytokine regulation of the human burst‐forming unit‐megakaryocyte, Blood, 76, pp. 516-522, (1990)
  • [6] de Sauvage F.J., Hass P.E., Spencer S.D., Malloy B.E., Gurney A.L., Spencer S.A., Darbonne W.C., Henzel W.J., Wong S.C., Wun-Jing K., Ole K.J., Hyltgren B., Solberg L.A., Goeddel D.V., Eaton D.L., Stimulation of megakaryocytopoiesis and thrombopoiesis by the c‐MpI ligand, Nature, 369, pp. 533-538, (1994)
  • [7] Gordon M.S., Hoffman R., Growth factors affecting human thrombocytopenia: potential agents for the treatment of thrombocytopenia, Blood, 80, pp. 302-307, (1992)
  • [8] Hayward C.P.M., Kelton J.G., Immune thrombocytopenia, Current Opinion in Hematology, 1, pp. 265-273, (1993)
  • [9] Hoflman R., Regulation of megakaryocytopoiesis, Blood, 74, pp. 1196-1212, (1989)
  • [10] Kelton J.G., Murphy W.G., Lucarelli A., Garvey-Williams J., Santos A., Meyer R., Powers P., A prospective comparison of four techniques for measuring platelet‐associated IgG, British Journal of Haematology, 71, pp. 97-105, (1989)